Back
An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome
Journal article

An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome

  • Drexel, Heinz Drexel University College of Medicine, Philadelphia, PA, USA
  • Coats, Andrew J S Monash University, Melbourne, Australia
  • Spoletini, Ilaria ORCID Department of Medical Sciences, Centre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy
  • Bilato, Claudio Division of Cardiology, West Vicenza General Hospitals, Vicenza, Italy
  • Mollace, Vincenzo Institute for Food Safety & Health University, ‘Magna Graecia of Catanzaro’, Catanzaro, Italy
  • Perrone Filardi, Pasquale Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
  • Rosano, Giuseppe M C Department of Medical Sciences, Centre for Clinical and Basic Research, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy
Show more…
  • 2019-12-24
Published in:
  • European Heart Journal - Cardiovascular Pharmacotherapy. - Oxford University Press (OUP). - 2019, vol. 6, no. 2, p. 115-121
English Abstract
Benefits and safety on statins have been well-established over 20 years of research. Despite this, the vast majority of patients are not adequately treated and do not achieve the low-density lipoprotein cholesterol target levels. This is mainly due to poor adherence, which is associated with dangerous and sometimes fatal outcomes. To increase adherence and prevent worse outcomes, a combination therapy with lower dosage of statins and new lipid-lowering drugs may be used. However, the implementation of new lipid-lowering drugs in European countries is still at the beginning. For these reasons, the aim of this position paper is to give an up-to-date indication from the ESC Working Group on Cardiovascular Pharmacotherapy in order to discuss the barriers towards statins adherence and new lipid-lowering drugs implementation in Europe.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/192809
Statistics
Document views: 43 File downloads: